[对先天性血友病的平衡疗法]
1Department of Laboratory Medicine, Tokyo Medical University.
概括
重新平衡疗法通过向组织因子通路抑制剂 (TFPI),抗血素 (AT) 和激活蛋白C (APC) 来提供一种新的血友病治疗方法. 这一创新策略旨在通过调节凝血和抗凝血通路来纠正出血倾向.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 传统的血友病治疗可以取代缺失的凝血因子.
- 一个新的治疗概念,再平衡疗法,已经出现.
- 这种疗法旨在通过调整凝血和抗凝血平衡来纠正出血.
研究的目的:
- 概述血友病再平衡治疗的概念.
- 介绍重新平衡疗法的临床试验结果.
- 讨论与这种治疗方法相关的预防措施和潜在问题.
主要方法:
- 向组织因子通路抑制剂 (TFPI) 具有单克隆抗体 (康齐祖马布,马斯塔西马布).
- 使用siRNA (fitusiran) 来降低抗血素 (AT) 合成.
- 使用SerpinPC来抑制活性蛋白C (APC).
主要成果:
- 抗TFPI药物 (康西苏巴,马斯塔西马布) 通过抑制TFPI与FXa和TF/FVIIa的结合来改善静血功能.
- 菲图西兰降低了AT合成,而SerpinPC抑制了APC.
- 临床试验正在评估这些药物的疗效和安全性.
结论:
- 重新平衡疗法代表了血友病管理中的范式转变.
- 针对TFPI,AT和APC提供了一种控制出血的新策略.
- 进一步的研究和临床评估对于广泛采用至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Introduction to Hemostasis
9.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.0K
Venous Thrombosis IV: Nursing Management
25
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
25
Continuous Renal Replacement Therapy
155
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
155


